Vor Bio to Participate in the Oppenheimer's 35th Annual Healthcare Life Sciences Conference

Company Overview - Vor Bio is a clinical-stage cell and genome engineering company focused on transforming the standard of care for patients with blood cancers by engineering hematopoietic stem cells for targeted therapies post-transplant [3]. Event Participation - Vor Bio will participate in a fireside chat and host virtual 1x1 investor meetings at Oppenheimer's 35th Annual Healthcare Life Sciences Conference [1]. - The fireside chat is scheduled for Wednesday, February 12 at 12:00pm ET and will be available via live webcast and archived replay on the company's investor section [2].